A first-in-human dose-escalation study of ME-143, a second generation NADH oxidase inhibitor, in patients with advanced solid tumors

标题
A first-in-human dose-escalation study of ME-143, a second generation NADH oxidase inhibitor, in patients with advanced solid tumors
作者
关键词
ME-143, tNOX, Dose escalation, Isoflavone, Apoptosis
出版物
INVESTIGATIONAL NEW DRUGS
Volume 32, Issue 1, Pages 87-93
出版商
Springer Nature
发表日期
2013-03-23
DOI
10.1007/s10637-013-9949-4

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started